In just over four years, the Weill Cornell Medical Center Clinical and Translational Science Center (CTSC)has established a strong and highly effective clinical and translational science infrastructure spanning sixdiverse partners, each a center of excellence: Memorial Sloan-Kettering Cancer Center; Hospital for SpecialSurgery; Hunter College School of Nursing. Hunter College Gene Center-a Research Center for MinorityInstitutions (RCMI); Cornell University Cooperative Extension; and Cornell University, Ithaca. The mission ofthe CTSC in continuation is to leverage the resources and expertise of this rich multi-institutional partnershipto create new interdisciplinary teams and support cutting-edge research from bench to bedside to communityto health care practice. The proposed grant adds a new partner, the Animal Medical Center a few blocksfrom WCMC, to increase collaboration with Cornell University College of Veterinary Medicine. Jointly, theybring a new dimension to our CTSC research and their expertise in small animals will enhance pre-clinicalresearch in the area of drug discovery and device development.Built on the accomplishments achieved during the initial funding period, the strategic plans for the next fiveyears are geared to rapidly advance translational science discoveries by: 1) Enhancing the Drug DiscoveryPipeline; 2) Increasing the Breadth of Research Resources; 3) Adding New Expertise and TrainingPrograms; and 4) Enhancing Community Engagement and Dissemination. Moving forward, the anticipatedbenefits of fostering 'Innovation through Collaboration' during the next funding period include: 1) Furthergeneration of novel ideas leading to drug development and medical devices which benefit patient care; 2)Increased collaborative efforts with partners and industry, to facilitate research to improve the general healthofthe public; 3) Enhanced clinical translational (C/T) educational programs in comparative effectivenessresearch, global health and health information technology; 4) Enhanced community engagement; 5)Increased centralization of C/T research, education, infrastructure, and databases; and 6) Enhancedevaluation and tracking of CTSC programs.

Public Health Relevance

The broad research support infrastructure ofthe CTSC and its programs to foster interactions among basicscientists, clinicians and community practitioners are key to the rapid translation of basic science discoveriesinto effective clinical practice. Our CTSC is distinct in the heterogeneity of its component institutions,providing unparalleled opportunities for collaboration and training in all areas of biomedical sciences.PROJECT/RERFORMANCE SITE(S) (if additional space is needed, use

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
2UL1TR000457-06
Application #
8467203
Study Section
Special Emphasis Panel (ZRR1-CR-1 (01))
Program Officer
Sufian, Meryl
Project Start
2007-09-17
Project End
2017-05-31
Budget Start
2012-06-27
Budget End
2013-05-31
Support Year
6
Fiscal Year
2012
Total Cost
$9,406,232
Indirect Cost
$1,838,395
Name
Weill Medical College of Cornell University
Department
Type
Schools of Medicine
DUNS #
060217502
City
New York
State
NY
Country
United States
Zip Code
10065
Zhang, Haijun; Yang, Jing; Walters, Matthew S et al. (2018) Mandatory role of HMGA1 in human airway epithelial normal differentiation and post-injury regeneration. Oncotarget 9:14324-14337
Chen, Feng; Zhang, Xiuli; Ma, Kai et al. (2018) Melanocortin-1 Receptor-Targeting Ultrasmall Silica Nanoparticles for Dual-Modality Human Melanoma Imaging. ACS Appl Mater Interfaces 10:4379-4393
Giza, Joanna I; Kim, Jihye; Meyer, Heidi C et al. (2018) The BDNF Val66Met Prodomain Disassembles Dendritic Spines Altering Fear Extinction Circuitry and Behavior. Neuron 99:163-178.e6
Chen, Jonathan; Wu, Xian; Christos, Paul J et al. (2018) Practice patterns and outcomes for patients with node-negative hormone receptor-positive breast cancer and intermediate 21-gene Recurrence Scores. Breast Cancer Res 20:26
Thareja, Gaurav; Yang, Hua; Hayat, Shahina et al. (2018) Single nucleotide variant counts computed from RNA sequencing and cellular traffic into human kidney allografts. Am J Transplant 18:2429-2442
Deferio, Joseph J; Levin, Tomer T; Cukor, Judith et al. (2018) Using electronic health records to characterize prescription patterns: focus on antidepressants in nonpsychiatric outpatient settings. JAMIA Open 1:233-245
Moore, Maureen D; Finnerty, Brendan; Gray, Katherine D et al. (2018) Decreased UCHL1 expression as a cytologic biomarker for aggressive behavior in pancreatic neuroendocrine tumors. Surgery 163:226-231
Aherne, Emily A; Pak, Linda M; Goldman, Debra A et al. (2018) Intrahepatic cholangiocarcinoma: can imaging phenotypes predict survival and tumor genetics? Abdom Radiol (NY) 43:2665-2672
Ghosh, Arnab; Mailankody, Sham; Giralt, Sergio A et al. (2018) CAR T cell therapy for multiple myeloma: where are we now and where are we headed? Leuk Lymphoma 59:2056-2067
Namasivayam, Sivaranjani; Sher, Alan; Glickman, Michael S et al. (2018) The Microbiome and Tuberculosis: Early Evidence for Cross Talk. MBio 9:

Showing the most recent 10 out of 756 publications